Aligos Therapeutics, Inc.
ALGS
$7.55
-$0.82-9.80%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 43.09M | -82.15M | -19.26M | 5.06M | -34.86M |
| Total Depreciation and Amortization | 194.00K | 671.00K | 667.00K | 610.00K | 282.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -60.36M | 63.47M | 1.67M | -29.28M | 17.33M |
| Change in Net Operating Assets | -3.84M | -390.00K | -3.18M | 4.11M | -5.49M |
| Cash from Operations | -20.91M | -18.40M | -20.10M | -19.49M | -22.75M |
| Capital Expenditure | -43.00K | -28.00K | -26.00K | -7.00K | -69.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -44.02M | 20.00M | 10.42M | 40.00M | -88.57M |
| Cash from Investing | -44.07M | 19.97M | 10.40M | 39.99M | -88.64M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -43.00K | -5.00K | -16.00K | -19.00K |
| Issuance of Common Stock | 101.74M | 140.00K | 1.00K | 297.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 101.74M | 97.00K | -4.00K | 281.00K | -19.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 36.77M | 1.67M | -9.71M | 20.78M | -111.41M |